A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -69.44% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -71.64%. Over the past 30 days, the price of ALZN has leaped by -23.68%. And in the last five days, it has fallen by -14.25%.
Alzamend Neuro Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $135.54 on 08/19/24, while the lowest value for the same period was recorded at $3.06 on 06/12/25.
52-week price history of ALZN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Alzamend Neuro Inc’s current trading price is -97.65% away from its 52-week high, while its distance from the 52-week low is 4.39%. The stock’s price range during this period has varied between$3.06 and $135.54. The Alzamend Neuro Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.28 million for the day, a figure considerably lower than their average daily volume of 1.46 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Alzamend Neuro Inc (ALZN) has experienced a quarterly decline of -48.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.56M and boasts a workforce of 7 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
ALZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALZN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
